Dr. E.P.M. (Elpetra) Timmermans-Sprang

Prof. dr. H. Jakobgebouw
Yalelaan 108
3584 CM Utrecht

Dr. E.P.M. (Elpetra) Timmermans-Sprang

Researcher and Teacher
Internal Medicine of Companion Animals

Publications

2026

Scholarly publications

van den Berg, M. F., Timmermans-Sprang, E. P. M., Zethof, J., Kusters, B., Olthaar, A., van Herwaarden, A. E., van Wolferen, M. E., Timmers, H. J. L. M., Kooistra, H. S., Dona, M., & Galac, S. (2026). Long-term culture of patient-derived pheochromocytoma organoids. Frontiers in Endocrinology, 17, Article 1781556. [DOI] [Repository]
van Bokhorst, K. L., van den Berg, M. F., Kooistra, H. S., van Wolferen, M. E., Timmermans-Sprang, E. P. M., Corsini, A., Golinelli, S., Bechmann, N., Peitzsch, M., & Galac, S. (2026). Glucocorticoid and mineralocorticoid production in hormonally silent adrenocortical tumor tissue in dogs. Journal of Veterinary Internal Medicine, 40(1), Article aalaf087. [DOI] [Repository]

2025

Scholarly publications

van den Berg, M. F., Timmermans-Sprang, E. P. M., Viets, F. C., van den Berg, L., Danawar, F., van Wolferen, M. E., Kooistra, H. S., Grinwis, G. C. M., de Jong, W. H. A., van Faassen, M., & Galac, S. (2025). Canine adrenomedullary and pheochromocytoma organoids: a novel in vitro model. Endocrinology, 166(9), Article bqaf114. [DOI] [Repository]

2024

Scholarly publications

Timmermans, E. P. M., Blankevoort, J., Grinwis, G. C. M., Mesu, S. J., Gehring, R., Delhanty, P. J. D., Maas, P. E. M., Strous, G. J., & Mol, J. A. (2024). In Vivo Effects of a GHR Synthesis Inhibitor During Prolonged Treatment in Dogs. Pharmaceuticals (Basel, Switzerland), 17(10), Article 1381. [DOI] [Repository]
van den Berg, M. F., Bechmann, N., Kooistra, H. S., van Wolferen, M. E., Timmermans-Sprang, E. P. M., Peitzsch, M., & Galac, S. (2024). Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites. Journal of Veterinary Internal Medicine, 38(5), 2415-2424. [DOI] [Repository]

2023

Scholarly publications

van den Berg, M. F., Kooistra, H. S., Grinwis, G. C. M., Nicoli, S., Golinelli, S., Stammeleer, L., van Wolferen, M. E., Timmermans-Sprang, E. P. M., Zandvliet, M. M. J. M., van Steenbeek, F. G., & Galac, S. (2023). Whole transcriptome analysis of canine pheochromocytoma and paraganglioma. Frontiers in Veterinary Science, 10, Article 1155804. [DOI] [Repository]
van der Krift, F., Zijlmans, D. W., Shukla, R., Javed, A., Koukos, P. I., Schwarz, L. LE., Timmermans-Sprang, E. P., Maas, P. E., Gahtory, D., van den Nieuwboer, M., Mol, J. A., Strous, G. J., Bonvin, A. M., van der Stelt, M., Veldhuizen, E. J., Weingarth, M., Vermeulen, M., Klumperman, J., & Maurice, M. M. (2023). A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance. Life Science Alliance, 6(11), Article e202302058. [DOI] [Repository]

2022

Scholarly publications

van der Velden, L. M., Maas, P., van Amersfoort, M., Timmermans-Sprang, E. P. M., Mensinga, A., van der Vaart, E., Malergue, F., Viƫtor, H., Derksen, P. W. B., Klumperman, J., van Agthoven, A., Egan, D. A., Mol, J. A., & Strous, G. J. (2022). Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesis. Frontiers in Endocrinology, 13, 1-14. Article 926210. [DOI] [Repository]

2021

Scholarly publications

Sanders, K., Veldhuizen, A., Kooistra, H. S., Slob, A., Timmermans-Sprang, E. P. M., Riemers, F. M., Daminet, S., Fracassi, F., van Nimwegen, S. A., Meij, B. P., & Galac, S. (2021). Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome. Frontiers in Veterinary Science, 8, 1-12. Article 760487. [DOI] [Repository]

2019

Scholarly publications

Timmermans-Sprang, E. (2019). Wnt Signaling in Canine Mammary Cancer. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. [Repository]
Timmermans-Sprang, E., Collin, R., Henkes, A., Philipsen, M., & Mol, J. A. (2019). P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines. Oncotarget, 10(31), 2930-2946. [DOI], [DOI] [Repository]
Timmermans-Sprang, E. P. M., Mestemaker, H. M., Steenlage, R. R., & Mol, J. A. (2019). Dasatinib inhibition of cSRC prevents the migration and metastasis of canine mammary cancer cells with enhanced Wnt and HER signaling. Veterinary and Comparative Oncology, 17(3), 413-426. [DOI] [Repository]

2018

Scholarly publications

Verhoeven, C., Sprang, E. P. M., Liu, JS., Gracanin, A., Coelingh Bennink, H. J. T., & Mol, J. A. (2018). Fetal Estetrol (E4) Inhibits Growth Hormone (GH) Signal Transduction in Breast Cancer Cell Lines. Austin Journal of Obstetrics and Gynecology, 5(7), Article 1123. http://austinpublishinggroup.com/obstetrics-gynecology/download.php?file=fulltext/ajog-v5-id1123.pdf [Repository]

2017

Scholarly publications

Selvarajah, G. T., Bonestroo, F. A. S., Timmermans Sprang, E. P. M., Kirpensteijn, J., & Mol, J. A. (2017). Reference gene validation for gene expression normalization in canine osteosarcoma: a geNorm algorithm approach. BMC Veterinary Research, 13, Article 354. [DOI] [Repository]
Timmermans-Sprang, E. P. M., Gracanin, A., & Mol, J. A. (2017). Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification. Frontiers in Veterinary Science, 4, Article 53. [DOI] [Repository]

2015

Scholarly publications

Timmermans-Sprang, E. P. M., Gracanin, A., & Mol, J. A. (2015). High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression. BMC Cancer, 15(545). [DOI] [Repository]

2014

Scholarly publications

Gracanin, A., Timmermans-Sprang, E. P. M., van Wolferen, M. E., Rao, N. A. S., Grizelj, J., Vince, S., Hellmen, E., & Mol, J. A. (2014). Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression. PLoS One, 9(6), Article e98698. [DOI] [Repository]
Gracanin, A., Voorwald, F. A., van Wolferen, M., Timmermans-Sprang, E., & Mol, J. A. (2014). Marginal activity of progesterone receptor B (PR-B) in dogs but high incidence of mammary cancer. Journal of Steroid Biochemistry and Molecular Biology, 144 Pt B, 492-9. [DOI]

2013

Scholarly publications

Selvarajah, G., Kirpensteijn, J., Kik, M., Sprang, E. P. M., & Mol, J. (2013). Heat shock protein expression analysis in canine osteosarcoma reveals hsp90 as a potentially relevant therapeutic target. Cell Stress and Chaperones, 18(5), 607-22. Article PMC3745254.

2008

Scholarly publications

Timmermans-Sprang, E. P. M., Rao, N. A., & Mol, J. A. (2008). Transactivation of a growth hormone (GH) promoter-luciferase construct in canine mammary cells. Domestic Animal Endocrinology, 34(4), 403-410.

2002

Scholarly publications

Poffers, J., Lumeij, J. T., Timmermans-Sprang, E. P. M., & Redig, P. T. (2002). Further studies on the use of allopurinol to reduce plasma uric acid concentrations in the Red-tailed Hawk (Buteo jamaicensis) hyperuricaemic model. Avian Pathology, 31(6), 567-72. [DOI]
Peeters, M., Sprang, E. P. M., & Mol, J. (2002). Feline thyroid adenomas are in part associated with mutations in the G (s alpha)gene and not with polymorphisms found in the thyrotropin receptor. Thyroid, 12(7), 571-5. Article pmid12193300.
Lantinga-van Leeuwen, I. S., Timmermans-Sprang, E. A. P., & Mol, J. A. (2002). Cloning and characterization of the 5'-flanking region of the canine growth hormone gene. Molecular and Cellular Endocrinology, 197(1-2), 133-41. [DOI]

1999

Scholarly publications

van Vonderen, I. K., Kooistra, H. S., Sprang, E. P., & Rijnberk, A. (1999). Disturbed vasopressin release in 4 dogs with so-called primary polydipsia. Journal of Veterinary Internal Medicine, 13(5), 419-25. [DOI]

1998

Scholarly publications

Lumeij, J. T., Sprang, E. P., & Redig, P. T. (1998). Further studies on allopurinol-induced hyperuricaemia and visceral gout in red-tailed hawks (Buteo jamaicensis). Avian Pathology, 27(4), 390-3. [DOI]

1997

Scholarly publications

Mol, J. A., Selman, P. J., Sprang, E. P., van Neck, J. W., & Oosterlaken-Dijksterhuis, M. A. (1997). The role of progestins, insulin-like growth factor (IGF) and IGF-binding proteins in the normal and neoplastic mammary gland of the bitch: a review. Journal of reproduction and fertility. Supplement, 51, 339-44.
van Wijk, P. A., Rijnberk, A., Croughs, R. J. M., Meij, B. P., van Leeuwen, I. S., Sprang, E. P. M., & Mol, J. A. (1997). Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-depen dent hyperadrenocorticism. Journal of Endocrinological Investigation, 20, 1-7.

1995

Scholarly publications

Goossens, M. M., Meyer, H. P., Voorhout, G., & Sprang, E. P. (1995). Urinary excretion of glucocorticoids in the diagnosis of hyperadrenocorticism in cats. Domestic Animal Endocrinology, 12(4), 355-62. [DOI]

1992

Scholarly publications

Van Wijk, P. A., Rijnberk, A., Croughs, R. J., Voorhout, G., Mol, J. A., & Sprang, E. P. M. (1992). Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism. Endocrinology, 131(6), 2659-62. [DOI]